Page results
-
The department of Thoracic Medicine at UCH has particular expertise in the management of patients with bronchiectasis and respiratory infections (including fungal disease, lung abscess and opportunistic infections).
-
Patient information for patients dealing with difficult feelings. This information will give you useful advice about what to do if you find yourself in a crisis.
-
Out-patient IV antibiotic service
-
OPAT (Outpatient Parenteral Antimicrobial Therapy) is a safe and convenient way to receive intravenous (IV) antibiotic therapy at home or in a clinic.
-
Advice on managing education for young people living with fatigue conditions.
-
Advice on relaxation techniques for young people living with fatigue conditions.
-
Intrauterine insemination (IUI) is a type of fertility treatment. It is commonly used for women who are using donated sperm in their treatment.
-
Anticoagulants are medicines that help prevent blood clots. They're given to people at a high risk of getting clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.
-
Myeloproliferative neoplasms (MPN) are disorders that affect how the body produces red blood cells, white blood cells, and platelets.
-
Please see below for information relating to various vaccination services offered at UCLH. To check which vaccinations you’ve had in the past, view your GP record using your NHS account or…
File results
-
FOI/2023/0235 - Hip and knee arthroplasty litigation
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0214 - Patients waiting over 78 weeks for elective care
-
FOI/2023/0215 - British sign language procurement and communications
-
FOI/2023/0217 - Integration platform(s) at the Trust
-
FOI/2023/0218 - System for discharge letters, diagnostic reporting, digital dictation & bed management
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment
-
FOI/2023/0227 - Number of radiographers and nuclear medicine clinical scientists at Trust
-
FOI/2023/0226 - Treatment with Nivolumab